Followers | 145 |
Posts | 27565 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Tuesday, December 14, 2021 4:37:41 AM
December 13 2021 - 01:35PM
In a report released today, Matthew Cross from Alliance Global Partners maintained a Buy rating on Gamida Cell (GMDA – Research Report), with a price target of $11.00. The company's shares closed last Monday at $2.33, close to its 52-week low of $2.25. According to TipRanks.com, Cross is ranked #2333 out of 7742 analysts. Gamida Cell has an analyst consensus of Strong Buy, with a price target consensus of $14.50. See the top stocks recommended by analysts >> The company has a one-year high of $15.00 and a one-year low of $2.25. Currently, Gamida Cell has an average volume of 380.9K.
https://www.tipranks.com/news/blurbs/alliance-global-partners-thinks-gamida-cells-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM